Xolair 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DX25F6AEL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $23,708
Award facts
- Contract value 100% obligated
- $23,707.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 27, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $23,707.62 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml syringes. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, with the place of performance located in Park Ridge, Illinois. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc., a pharmaceutical wholesaler headquartered in Park Ridge, Illinois, operates as a crucial supplier within the federal pharmaceutical supply chain. This delivery order is issued under the company's significant Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026, which enables the issuance of firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide. The company has demonstrated consistent success in federal procurement, leveraging its woman-owned small business designation to secure multiple contracts for specialty medications, biologics, and medical consumables serving Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DX25F6AEL?
SPE2DX25F6AEL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25F6AEL worth?
The government has obligated $23,708 on SPE2DX25F6AEL.
Is contract SPE2DX25F6AEL an order under another contract?
Yes. SPE2DX25F6AEL is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEL competed?
The extent of competition for SPE2DX25F6AEL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award